will lake’ avrg ne is ed st Reel con ace sac “portal nena & eneMhrlleoy ho &ey anwain wil Lal sale ni fa em ‘ eee fap. on ae ‘Wea di ava ‘ten | beay bamed EWI se tFirst Once-A-Month Birth Control Option Now Available In TU.S. (NAPS)—Oneout of two women would prefer a more convenient monthly birth control method that is similar to tpill, according to a recent national survey of more than 450 womenin tU.S. con- ducted by ACNielsen International Research. Tsurveyalso foundthat: Only 32 percent of women are currently taking tpill and 57 percent of women whoused tpill have forgotten to takeit. 80 percent of women expect their birth control to be reliable, 69 percent safe and 68 percent convenient. Only one out of two women talk to their physician about new birth control choices, yet a major- New contraceptive methods offer women tconvenience of once-a-month dosing. “With my busy schedule, I find Lunelle™ more convenient than taking a pill every day. I’m out of my health care provider’s office in ity of women want a morereli- less than 15 minutes just once a month,” says Roslyn Tate, a clini- Tfindings prompted a panel used tproduct for more than three years. able, safe and convenient birth control method. of women’s health experts to urge increased access to birth control methods nottied to daily pill tak- ing or tmomentofintimacy. On Oct. 5, 2000, tFDA ap- proved Lunelle” Monthly Contra- ceptive Injection (medroxyprogesterone acetate estradiol cypionate injectable suspension), tfirst cal study participant, who has TACNielsen survey was sup- ported by an unrestricted grant from tPharmacia Corporation, which manufactures Lunelle™ and Depo-Provera Contraceptive Injection, a long-acting birth control option for women who wantto postpone pregnancy. As with other contraceptives and only monthly birth control option for American women. Tcontaining a combination of estro- available by prescription, has contraceptive benefits similar to tmay be associated with an increased risk of cardiovascular side combined hormonal injection, now gen and progestin, Lunelle™ is not appropriate for some women. It pill, yet offers women tconve- effects, which increase with heavy nience of once-a-month dosing. “I think Lunelle™ is going to meet a big need for womenin this country—it has contraceptive benefits similar to tpill yet is administered only once a month,” said Anita Nelson, M.D., University of California Harbor Medical Center and U.S. clinical trial investigator. “It is more than 99 percent effective when administered as scheduled, offering womena reliable and convenient new birth control option.” smoking and age, especially in womenover tage of 35. Like other hormonal contraceptives, women may experience altered bleeding patterns when using tmonthly injectable. Taverage weight gain of women in tU.S. clinical trial over one year on it was four pounds. For more information about this monthly birth control option, please call 1-800-752-8779or visit www.lunelle.com or www.birth controlresources.com.
